Print Article

February 2012
The essential resource for your practice
Volume XXI, Number 2
Table of Contents
Register Now for the 2012 Urology Joint Advocacy Conference
AUA Names New Health Policy Vice Chair
2011: Health Policy Year in Review
Availability of Medicare Claims Data for Performance Measurement
AUA Physicians and Staff Meet with CIGNA Representatives
Delegates Attend AMA House of Delegates Meeting, AUA Leads Effort to Stop ICD-10 Implementation
Health Policy Council, Committees Hold Fall Meetings
For the Record
December MedPAC Meeting Focuses on Payment Adequacy
Outreach Observer: Are You HIPAA Compliant?
Recap: Practice Management Committee Fall Meeting
Recap: Practice Guidelines Committee Fall Meeting
Recap: Quality Improvement and Patient Safety Committee Fall Meeting
Recap: Legislative Affairs Committee Fall Meeting
Recap: Coding & Reimbursement Committee Fall Meeting
Fall Committee Meeting Photos
Government Relations and Advocacy (GR&A) Department Year in Review
Guidelines Department Year in Review
Practice Management Department Year in Review
Quality Year in Review
Reimbursement & Regulation Year in Review

  

Recap: Quality Improvement and Patient Safety Committee Fall Meeting

The Quality Improvement and Patient Safety (QIPS) Committee, consisting of AUA members selected for their knowledge and expertise and representing a wide array of geographic and practice diversity, met on Friday, November 18, 2011, under the guidance of Chair J. Quentin Clemens, MD, MSCI. There were two primary highlights from the meeting: (1) a White Paper on Infectious Complications after Prostate Needle Biopsies; and (2) the U.S. Food and Drug Administration’s (FDA) update on Synthetic Surgical Mesh.

At the May QIPS meeting, the committee discussed the increase in the reports of sepsis and infectious complications after prostate needle biopsies and decided to address the issue through both a short- and long-term approach. In the short-term, a blast e-mail detailing the AUA’s stance on prostate biopsy related sepsis was sent to all AUA members through the AUA Daily Scope and other AUA communications vehicles. The long-term approach was to create a white paper. Thus, an AUA workgroup was formed, and the Society of Urologic Nurses and Associates (SUNA) was invited to participate. At the time of the November QIPS meeting, the group had developed an outline and was conducting a literature search. They hope to have rough draft completed by January/February.

In October 2010, the FDA announced they were seeing many complications with mesh. In July 2011, they issued an update which was much more negative about the use of mesh, and they noted that complications from mesh are not rare. In September 2011 the FDA presented their findings at a public hearing and allowed for comments on mesh for prolapse and mesh for stress urinary incontinence surgery. Drs. Victor Nitti and Chris Winters presented for the Society for Female Urology and Urodynamics (SUFU) and the AUA respectively at this hearing. Their statements were also coordinated with those of the American Urogynecologic Society (AUGS) and the Society of Gynecologic Surgeons (SGS) to ensure a united response.

Following the hearing, the AUA formed a workgroup to draft statements on both the use of vaginal mesh for the repair of pelvic organ prolapse and for the surgical treatment of stress urinary incontinence. Both statements were unanimously approved by the QIPS Committee and were submitted to the Health Policy Council and then the Board of Directors. Click to view the statements on the use of vaginal mesh for the repair of pelvic organ prolapse and for the surgical treatment of stress urinary incontinence.